Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles W Carroll

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Viral vectors for cancer immunotherapyRichard Harrop, Miles W Carroll
Vaccine|March 26, 2013
Recombinant MVA vaccines: dispelling the mythsMatthew G Cottingham, Miles W Carroll
Advanced Drug Delivery Reviews|October 13, 2006
Recombinant viral vectors: cancer vaccinesRichard Harrop, Justin John, Miles W Carroll
Ebiomedicine|January 3, 2026
Current knowledge on the host-pathogen interactions of henipaviruses and novel platforms to enable further characterisationJakub Hantabal, F Javier Salguero, Miles W Carroll
Vaccine|July 9, 2017
Development of vaccines against Crimean-Congo haemorrhagic fever virusStuart D Dowall, Miles W Carroll, Roger Hewson
Frontiers in Immunology|March 8, 2021
Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of ProtectionStephanie Longet, Jack Mellors, Miles W Carroll, et al.
Frontiers in Immunology|April 17, 2023
Pre-clinical models to define correlates of protection for SARS-CoV-2Caolann Brady, Tom Tipton, Stephanie Longet, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Monitoring of human immunological responses to vaccinia virusRichard Harrop, Matthew G Ryan, Hana Golding, et al.
Immunology|April 25, 2006
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4Irina Redchenko, Richard Harrop, Matthew G Ryan, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic ApplicationAlexander Hargreaves, Caolann Brady, Jack Mellors, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Viral vectors for cancer immunotherapyRichard Harrop, Miles W Carroll
Vaccine|March 26, 2013
Recombinant MVA vaccines: dispelling the mythsMatthew G Cottingham, Miles W Carroll
Advanced Drug Delivery Reviews|October 13, 2006
Recombinant viral vectors: cancer vaccinesRichard Harrop, Justin John, Miles W Carroll
Ebiomedicine|January 3, 2026
Current knowledge on the host-pathogen interactions of henipaviruses and novel platforms to enable further characterisationJakub Hantabal, F Javier Salguero, Miles W Carroll
Vaccine|July 9, 2017
Development of vaccines against Crimean-Congo haemorrhagic fever virusStuart D Dowall, Miles W Carroll, Roger Hewson
Frontiers in Immunology|March 8, 2021
Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of ProtectionStephanie Longet, Jack Mellors, Miles W Carroll, et al.
Frontiers in Immunology|April 17, 2023
Pre-clinical models to define correlates of protection for SARS-CoV-2Caolann Brady, Tom Tipton, Stephanie Longet, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Monitoring of human immunological responses to vaccinia virusRichard Harrop, Matthew G Ryan, Hana Golding, et al.
Immunology|April 25, 2006
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4Irina Redchenko, Richard Harrop, Matthew G Ryan, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic ApplicationAlexander Hargreaves, Caolann Brady, Jack Mellors, et al.
Pageof 15